Quality Management Systems (QMS), Quality Assurance (QA), and Quality Control (QC) in pharmaceutical technology covers essential principles and practices vital for ensuring product quality and regulatory compliance. By exploring the interplay between QMS, QA, and QC, you will appreciate the holistic approach to maintaining product quality throughout the drug development lifecycle. Continuous improvement strategies within QMS, QA, and QC frameworks will also be emphasized to enhance operational efficiency and effectiveness in pharmaceutical processes.
#QualityAssurance #QualityControl #QMS #QualityManagementSystem #ISO9001 #ContinuousImprovement #QualityAudit #QualityPolicy #RiskManagement #CorrectiveAction #PreventiveAction #TotalQualityManagement #PharmaceuticalIndustry #PharmaceuticalManufacturing #ProcessImprovement #QualityObjectives #QualityPlanning #QualityTools #PDCA #CAPA(CorrectiveandPreventiveAction) #Validation #Verification #QualityMetrics #QualityStandards #QualitySystemRegulation #RegulatoryCompliance #Accreditation #Certification #QualityGurus #QualityImprovement #StatisticalProcessControl #ControlCharts #QualityManual #StandardOperatingProcedures #QualityManagementPrinciples #QualityCulture #QualityTraining #QualityInspection #QualityTechnician #QualityEngineer #QualityManager
Learning Outcomes
Understand the principles and importance of Quality Management Systems (QMS) in pharmaceutical technology.
Demonstrate proficiency in implementing QMS strategies to ensure compliance with industry standards and regulations.
Analyze the roles and responsibilities of quality assurance (QA) in preventing defects and ensuring product safety and efficacy.
Apply quality control (QC) methods and techniques to inspect and evaluate pharmaceutical products for compliance with specifications.
Evaluate the interplay between QMS, QA, and QC in maintaining product quality throughout the drug development lifecycle.
Develop strategies for continuous improvement within QMS, QA, and QC frameworks to enhance efficiency and effectiveness in pharmaceutical operations.
Quality Management Systems (QMS) serve as the backbone of quality assurance and control within the pharmaceutical industry. At its core, QMS embodies a systematic approach aimed at ensuring the consistent delivery of safe, effective, and high-quality products throughout the entire pharmaceutical lifecycle. By integrating various processes, procedures, and resources, QMS not only emphasizes adherence to regulatory requirements but also fosters a culture of continuous improvement and excellence within organizations.
QMS operates on the principle of systematic organization and coordination of activities to achieve predefined quality objectives. It entails the development and implementation of standardized processes, protocols, and documentation across all stages of the pharmaceutical lifecycle (from research and development to manufacturing, distribution, and post-market surveillance). By implementing a robust QMS, pharmaceutical companies can ensure that pharmaceutical products meet stringent quality, safety, and efficacy standards.
Definition and Component
A Quality Management System (QMS) is a comprehensive framework that encompasses organizational structures, procedures, processes, and resources aimed at ensuring consistent production of products or services that meet predefined quality standards, customer requirements, and regulatory obligations. It involves the systematic management of quality across all stages of the product lifecycle, from design and development through manufacturing, distribution, and post-market surveillance. The QMS integrates various elements, including quality planning, assurance, control, documentation, risk management, and continual improvement initiatives. By fostering a culture of quality, transparency, and accountability, QMS enables organizations to enhance customer satisfaction, mitigate risks, comply with regulatory mandates, drive operational efficiencies, and sustain long-term business success. Key components of QMS are summarized in the slider below:
Relevance of QMS to Stakeholders
Employers/Organizations
A robust QMS enhances efficiency, reduces errors, and minimizes risks, leading to improved productivity and profitability. It also fosters a culture of accountability and continuous improvement, promoting employee engagement and satisfaction.
Investors
A well-implemented QMS demonstrates organizational stability, reliability, and adherence to industry standards. This instills confidence in investors, leading to increased investment and potential growth opportunities.
Employees
A QMS provides clear guidelines, training, and support, ensuring that employees understand their roles and responsibilities. It fosters a sense of empowerment, job satisfaction, and professional development, contributing to a positive work environment.
Customers
A QMS ensures consistent product quality, timely delivery, and superior service, enhancing customer satisfaction and loyalty. It builds trust and credibility, leading to repeat business, positive referrals, and sustained competitiveness.
Regulatory Bodies
A QMS ensures compliance with regulatory requirements, standards, and legal obligations. It enables organizations to demonstrate due diligence, transparency, and accountability, mitigating risks of non-compliance, penalties, and reputational damage.
The quality policy is a formal statement by an organization outlining its commitment to quality and its approach to achieving quality objectives. It serves as a guiding principle for the organization’s quality management efforts. A quality policy should address the the following key components or embody these characteristics:
- The primary purpose of the quality policy is to communicate the organization’s dedication to quality to internal and external stakeholders. It serves as a guiding principle for decision-making and actions related to quality management.
- A quality policy typically includes (Content) statements regarding the organization’s commitment to meeting customer requirements, complying with regulations and standards, and continuously improving quality processes. It may also outline the responsibilities of employees in upholding quality standards.
- The quality policy should be aligned with the organization’s overall mission, vision, and values. It should reflect the organization’s strategic goals and objectives, particularly those related to customer satisfaction, product quality, and regulatory compliance.
- The quality policy should be communicated effectively throughout the organization, ensuring that all employees understand their role in maintaining quality standards. It may be posted in prominent locations within the workplace, included in employee handbooks, and discussed during training sessions.
- The quality policy should be periodically reviewed and updated to ensure its continued relevance and effectiveness. Changes in organizational goals, industry regulations, or customer expectations may necessitate revisions to the quality policy.
- The quality policy should have the full support and commitment of top management within the organization. Leaders should actively promote and reinforce the importance of quality throughout the organization.
Quality Objectives
Quality objectives are specific, measurable goals that an organization sets to achieve its quality policy. These objectives are aligned with the organization’s strategic goals and provide a framework for monitoring and improving quality performance. These quality objectives are specific, measurable, achievable, relevant, and time-bound (SMART), providing clear targets for the organization to work towards in pursuit of its quality policy.
Integration Across Pharmaceutical Life-Cycle
What sets QMS apart is its holistic approach to quality management, which spans the entire pharmaceutical lifecycle. From initial product development to post-market surveillance, QMS ensures that quality is ingrained into every aspect of the process. This integration fosters transparency, consistency, and accountability, ultimately leading to improved product quality, enhanced customer satisfaction, and regulatory compliance.
Quality planning, integral to a Quality Management System (QMS), systematically delineates quality objectives and identifies requisite resources, procedures, and activities for their effective attainment. This proactive approach aims to forestall defects, augment product quality, and fulfill customer requisites. Often iterative, quality planning entails ongoing review, refinement, and enhancement of plans to match evolving organizational dynamics and environmental shifts. This iterative nature enables adaptation to emerging challenges, assimilation of past learnings, and exploitation of improvement avenues. Continual assessment and adjustment of quality plans, grounded in feedback, performance metrics, and evolving demands, empower organizations to consistently elevate the caliber of their products or services.
Document control is a systematic process within a Quality Management System (QMS) that involves managing the creation, review, approval, distribution, and revision of documents related to quality management and regulatory compliance. This includes procedures, work instructions, forms, specifications, policies, and other documents critical to the organization’s operations. Some reasons or importance of Document Control you should be familiar with include:
- Document control ensures that all documents adhere to regulatory requirements and industry standards, helping organizations remain compliant with relevant regulations.
- By maintaining a centralized repository of controlled documents, document control reduces the risk of errors, inconsistencies, and outdated information, thereby enhancing operational efficiency and effectiveness.
- Document control assigns responsibility for document creation, review, and approval, fostering accountability and traceability throughout the document lifecycle.
- By providing a framework for document review and revision, document control facilitates ongoing improvement of processes, procedures, and documentation based on feedback and lessons learned.
Some Essential Documentation in a QMS
The slides below provides an overview of essential documents within a Quality Management System (QMS). It covers key documents such as SOPs, work instructions, quality policies, and audit reports, highlighting their importance in ensuring compliance, consistency, and continual improvement. With clear explanations and practical examples, this presentation equips viewers with a thorough understanding of the role and significance of QMS documents in maintaining quality standards and driving organizational excellence.
Strategies and Best Practices
How to Implement a Document Control Process
Training and competence are critical aspects of a Quality Management System (QMS) to ensure compliance with regulatory requirements, maintain product quality, and enhance patient safety. Training competence is also a fundamental component of QMS within the pharmaceutical industry, ensuring that personnel are equipped with the knowledge, skills, and competencies needed to maintain product quality, comply with regulations, and safeguard patient health. Effective training programs, coupled with rigorous competency assessments and continual improvement efforts, are essential for achieving and sustaining high levels of performance and regulatory compliance in the pharmaceutical sector.
Regulatory bodies such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency) require pharmaceutical companies to establish training programs to ensure that personnel are adequately trained and competent to perform their roles effectively. Compliance with Good Manufacturing Practices (GMP) regulations (see also the European Medicine Agency Good Manufacturing Practices) mandates that personnel involved in manufacturing, testing, and distribution undergo appropriate training and demonstrate competence in their assigned tasks.
Pharmaceutical companies must maintain comprehensive documentation and records of training activities to demonstrate compliance with regulatory requirements. This includes training plans, curricula, training materials, attendance records, competency assessments, and training effectiveness evaluations. Documentation should be accurate, up-to-date, and readily accessible for inspection by regulatory authorities.
Conducting a thorough training needs assessment is essential to identify gaps in knowledge, skills, and competencies among personnel. This assessment helps determine the specific training requirements for different job roles and functions within the organization. Training needs may vary based on factors such as job responsibilities, changes in technology, regulatory updates, and organizational goals.
Pharmaceutical companies should develop structured and comprehensive training programs tailored to the specific needs of employees. Training programs should cover topics such as GMP principles, standard operating procedures (SOPs), safety protocols, quality control techniques, regulatory requirements, and product-specific knowledge. Training materials should be clear, concise, and engaging to facilitate effective learning.
Competency assessments are used to evaluate the effectiveness of training programs and ensure that personnel have acquired the necessary knowledge and skills to perform their job functions competently. Assessments may include written tests, practical demonstrations, observations, and evaluations of job performance. Competency assessments should be conducted periodically and documented to demonstrate ongoing compliance with regulatory requirements.
Continuous improvement is essential to enhance training effectiveness and ensure ongoing compliance with regulatory requirements. Pharmaceutical companies should regularly review and evaluate their training programs to identify areas for improvement, update training materials in response to changes in regulations or best practices, and provide additional training as needed to address emerging challenges or opportunities.
The International Standards for Organization (ISO) 9001 is a globally recognized standard that provides a framework for implementing a QMS in any industry, including pharmaceuticals. It focuses on customer satisfaction, continuous improvement, and process efficiency, which are essential for pharmaceutical companies aiming to deliver high-quality products and services.
While ISO 9001 offers a generic framework for quality management, it may not address industry-specific requirements or regulatory standards specific to pharmaceuticals. Pharmaceutical companies may need to supplement ISO 9001 with additional standards or guidelines, such as GMP or ISO 13485, to ensure compliance with industry regulations.
ISO 9001 is suitable for pharmaceutical companies involved in various sectors, including manufacturing, distribution, and contract research organizations (CROs), that seek to improve overall quality management practices and enhance customer satisfaction.
Good Manufacturing Practices (GMP) is a set of regulations and guidelines established by regulatory authorities such as the FDA and EMA to ensure the quality, safety, and efficacy of pharmaceutical products. GMP provides specific requirements for manufacturing, testing, and quality control processes, helping pharmaceutical companies maintain consistent product quality and comply with regulatory standards.
GMP compliance requires strict adherence to detailed requirements and procedures, which can be resource-intensive and time-consuming for pharmaceutical companies. Additionally, GMP regulations are subject to frequent updates and revisions, requiring companies to stay informed and adapt their processes accordingly.
GMP is essential for pharmaceutical companies engaged in drug manufacturing, packaging, labeling, and distribution, as well as contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that provide services to pharmaceutical companies.
Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (APIs)- (ICH Q7) is an internationally recognized guideline developed by the International Council for Harmonisation (ICH) to establish GMP requirements for the manufacturing of active pharmaceutical ingredients (APIs). It provides comprehensive guidance on quality management practices, risk assessment, and documentation requirements specific to API manufacturing.
While ICH Q7 provides valuable guidance for API manufacturers, it may not cover all aspects of GMP relevant to finished pharmaceutical products. Pharmaceutical companies may need to integrate ICH Q7 with other GMP guidelines and regulatory requirements to ensure comprehensive compliance.
ICH Q7 is primarily relevant to pharmaceutical companies involved in the manufacturing of APIs, including both in-house API manufacturers and contract manufacturers supplying APIs to drug manufacturers.
Quality Risk Management (ICH Q9) provides guidelines for implementing a systematic approach to quality risk management (QRM) in pharmaceutical manufacturing and development. It helps companies identify, assess, and mitigate risks to product quality, safety, and efficacy throughout the product lifecycle. By proactively addressing potential risks, pharmaceutical companies can enhance product quality, ensure patient safety, and comply with regulatory requirements.
Implementing QRM according to ICH Q9 requires a cultural shift within organizations to prioritize risk management and foster a proactive approach to quality assurance. It also requires resources for training personnel, implementing risk assessment tools, and integrating risk management practices into existing quality systems.
ICH Q9 is relevant to pharmaceutical companies involved in all stages of drug development, manufacturing, and distribution. It is particularly valuable for companies engaged in process validation, product lifecycle management, and regulatory submissions, as well as contract research organizations (CROs) and contract manufacturing organizations (CMOs) that provide services to pharmaceutical companies.
Key Takeaways
Implementing a Quality Management System (QMS) offers numerous benefits to pharmaceutical companies, including improved product quality, enhanced customer satisfaction, regulatory compliance, and reduced risks of product recalls and liabilities.
- A QMS helps pharmaceutical companies maintain consistent quality standards throughout the product lifecycle, from development to manufacturing and distribution. By implementing robust quality control measures, adhering to Good Manufacturing Practices (GMP), and conducting thorough testing and validation procedures, companies can ensure that their products meet stringent quality requirements and specifications.
- A QMS focuses on meeting customer needs and expectations by delivering high-quality products that are safe, effective, and reliable. By consistently producing quality products and providing excellent customer service, pharmaceutical companies can build trust and loyalty among their customers, leading to increased satisfaction and repeat business.
- Compliance with regulatory requirements is essential for pharmaceutical companies to operate legally and market their products globally. A QMS helps companies ensure compliance with regulations such as Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Good Distribution Practices (GDP), as well as industry-specific standards like ISO 13485 for medical devices and ISO 17025 for testing laboratories.
- By implementing effective quality control measures and risk management processes, pharmaceutical companies can minimize the likelihood of defects, deviations, and non-conformances in their products. This reduces the risks of product recalls, adverse events, and liabilities associated with safety or quality issues, protecting both the company’s reputation and the well-being of patients.
Quality Assurance (QA) and Quality Control (QC) are two essential components of the pharmaceutical manufacturing process. While often used interchangeably, they serve distinct purposes in ensuring product quality and regulatory compliance.
QA encompasses the policies, procedures, and processes implemented to ensure that pharmaceutical products consistently meet quality standards and regulatory requirements. QA focuses on preventive measures to minimize risks and deviations throughout the manufacturing process. However, QC involves the activities and processes used to monitor and verify the quality of raw materials, in-process materials, and finished products. QC measures compliance with established quality standards and specifications through testing, inspection, and analysis.
Quality Assurance Objectives
- Establishing and maintaining quality management systems (QMS) to govern all aspects of manufacturing.
- Developing and implementing standard operating procedures (SOPs) to ensure consistency and compliance.
- Conducting risk assessments to identify potential hazards and mitigate risks to product quality.
- Ensuring compliance with regulatory requirements and industry standards through audits and inspections.
Quality Control Responsibilities
- Sampling and testing raw materials, in-process materials, and finished products to verify adherence to quality specifications.
- Conducting stability studies to assess the shelf-life and integrity of pharmaceutical products.
- Managing deviations and non-conformances through investigation, root cause analysis, and corrective actions.
- Maintaining accurate records of QC activities and results for documentation and regulatory purposes.
Quality Assurance and Product Quality
- Establishes the framework and standards for product quality through the development of QMS and SOPs.
- Ensures that manufacturing processes are designed and executed to prevent errors, deviations, and non-conformances.
- Conducts regular audits and inspections to verify compliance with quality standards and regulatory requirements.
Quality Control and Product Quality
- Monitors and verifies product quality throughout the manufacturing process through testing and analysis.
- Identifies deviations from established quality standards and takes corrective actions to maintain product quality and safety.
- Ensures that finished products meet predefined quality specifications before release to the market.
One of the primary goals of QMS is to ensure quality assurance at every step of the pharmaceutical lifecycle. QA and QC operates within a complementary framework to assure product quality. QA establishes quality frameworks and standards through QMS and SOP development. It ensures processes prevent errors and deviations, conducting regular audits for compliance. QC monitors and verifies product quality through testing, identifying deviations and taking corrective actions. QC ensures finished products meet quality specifications before release, working with QA to maintain high standards throughout pharmaceutical manufacturing.
Implementing Effective QA practices in Pharmaceutical Manufacturing involves several key steps to ensure robust processes and adherence to regulatory standards. Pharmaceutical companies must establish a comprehensive QMS that incorporates QA principles such as risk management, process validation, change control, and documentation practices. This involves defining quality objectives, developing SOPs, and implementing procedures for ongoing monitoring and improvement. Challenges in this process may include aligning diverse stakeholders’ perspectives, allocating sufficient resources, and integrating QA practices into existing workflows seamlessly.
Companies should conduct thorough risk assessments to identify potential hazards and vulnerabilities in the manufacturing process. This includes assessing risks related to raw materials, equipment, personnel, and environmental factors. By understanding and mitigating these risks, companies can minimize the likelihood of quality issues and ensure product safety and efficacy. Challenges may arise in prioritizing and addressing identified risks effectively, as well as in maintaining risk management processes over time amid evolving regulatory requirements and industry standards.
Ongoing training and education are essential to ensure staff competence and compliance with QA practices. Regular audits and inspections should be conducted to assess adherence to quality standards and identify areas for improvement. Additionally, companies should continuously evaluate and refine their QA processes based on performance data and feedback from stakeholders. Key considerations include fostering a culture of quality and continuous improvement, leveraging technology to streamline QA processes, and fostering collaboration across departments to drive quality excellence. By implementing these strategies and best practices, pharmaceutical companies can establish robust QA processes that enhance product quality, process efficiency, and regulatory compliance, ultimately ensuring the safety and efficacy of pharmaceutical products.
Optimizing QC Processes in Pharmaceutical Manufacturing involves several steps and strategies to ensure product quality, consistency, and regulatory compliance. Companies must establish comprehensive QC procedures encompassing raw material testing, in-process monitoring, finished product testing, and deviation management. This entails developing robust testing protocols, standardizing testing methodologies, and ensuring equipment calibration and validation to maintain accuracy and reliability.
Challenges in validating analytical methods and equipment in pharmaceutical manufacturing stem from process complexity and product diversity. Method validation ensures accuracy and precision, while equipment validation requires meticulous testing due to variability and calibration needs. Ensuring data integrity is crucial in electronic systems, requiring robust data management to prevent manipulation and unauthorized access. Effective deviation management is essential to promptly address issues and prevent recurrence, as failure can lead to quality issues, delays, and regulatory citations. Robust processes are vital to maintain product quality and compliance, emphasizing the importance of thorough validation and deviation management in pharmaceutical manufacturing.
Companies should prioritize ongoing training and skill development for personnel involved in quality control activities to ensure competence and adherence to quality standards. Regular audits and inspections should be conducted to evaluate the effectiveness of quality control processes and identify areas for improvement. Additionally, companies should leverage technology and data analytics to streamline quality control operations, automate routine tasks, and facilitate real-time monitoring and analysis. Key considerations include ensuring traceability and accountability in quality control processes, fostering a culture of quality and continuous improvement, and collaborating with suppliers and partners to maintain supply chain integrity. By addressing these challenges and implementing best practices, pharmaceutical companies can optimize quality control processes to enhance product quality, consistency, and compliance in manufacturing operations.
Conclusions
In addition to quality assurance, QMS places significant emphasis on quality control measures to monitor and verify the conformity of products to predefined quality standards and specifications. This involves establishing robust quality management policies, procedures, and practices to prevent defects, deviations, or non-conformities that could compromise product quality or patient safety. Quality assurance within QMS encompasses activities such as quality planning, risk management, supplier qualification, and validation of processes and systems.
Quality assurance establishes a framework guiding quality control activities. this includes conducting rigorous testing, inspections, and audits throughout the manufacturing process to detect any deviations or discrepancies that may arise. By implementing effective quality control mechanisms, organizations can promptly identify and address any issues to ensure that only products meeting the highest quality standards reach the market.
Case Study #1
Company- Immersion Pharmaceuticals
Scenario- Immersion Pharmaceuticals implemented a comprehensive QMS that included stringent quality control measures, GMP compliance, and regular audits and inspections. As a result, the company significantly improved the quality of its products, reduced manufacturing defects, and achieved higher levels of customer satisfaction. The implementation of the QMS also helped Immersion Pharmaceuticals maintain compliance with regulatory requirements and avoid costly product recalls.
Task- Analyze the successful implementation of a QMS at Immersion Pharmaceuticals, focusing on how it contributed to improved product quality, reduced defects, increased customer satisfaction, and ensured regulatory compliance. Discuss the key components and strategies of the QMS that led to these positive outcomes.
Case Study #2
Company- Immersion Biotech
Scenario- Immersion Biotech faced challenges with product quality and regulatory compliance due to inconsistencies in manufacturing processes and documentation errors. After implementing a QMS focused on process optimization, employee training, and quality assurance, Immersion Biotech saw a dramatic improvement in product quality and regulatory compliance. The company reduced the number of non-conformances and deviations, leading to fewer product recalls and enhanced credibility with regulatory authorities and customers.
Task- Examine the challenges faced by Immersion Biotech regarding product quality and regulatory compliance and evaluate how the implementation of a QMS addressed these issues. Assess the specific improvements achieved through process optimization, employee training, and quality assurance initiatives, and discuss the impact on reducing non-conformances, deviations, and product recalls.
Case Study
Scenario- A pharmaceutical company is experiencing frequent deviations and non-conformities in its manufacturing processes, leading to product quality issues and regulatory compliance concerns.
Prompt- Discuss the root causes of the deviations and non-conformities. Identify potential gaps in the company’s QMS, such as inadequate training, ineffective process controls, or insufficient documentation practices. Discuss strategies for addressing these challenges and implementing CAPA to improve product quality and compliance.
Group Activity
Scenario- Create groups with each representing a different department within a pharmaceutical company (e.g., manufacturing, quality control, regulatory affairs).
Prompt- Each group is responsible for a specific aspect of the QMS, such as document control, training and competence, or change management. Identify common challenges and best practices related to the assigned area of the QMS. Develop solutions to address the identified challenges and share the findings through presentations or group discussions.
Debate
Scenario- Create two teams representing opposing viewpoints on a QMS-related issue in the pharmaceutical industry (e.g., the role of automation in QMS implementation). Discussion should include challenges or best practices in implementing and maintaining a QMS.
Prompt- Be it Resolved, “Automation is essential for effective QMS implementation in pharmaceutical companies.” Each team should select a position to argue for or against the topic based on research and evidence. Present the arguments persuasively and engage in constructive dialogue to explore different perspectives.
Role-Playing Exercise
Scenario- Role-play different stakeholders involved in the implementation and maintenance of a QMS in a pharmaceutical company, such as senior management, quality assurance personnel, manufacturing operators, and regulatory affairs specialists.
Prompt- See the slides for a series of simulated scenarios or challenges related to QMS implementation, such as a regulatory inspection, a product recall, or a change management issue. Respond to the scenarios based on chosen role, considering the perspectives, responsibilities, and priorities of the respective stakeholders. Participate in a debriefing discussion to reflect on the outcomes and lessons learned.
Good Manufacturing Practice (GMP)
Principles of GMP
Food and Drug Administration (FDA)
FDA Regulations
European Medicine Agency (EMA)
Regulations
Good Laboratory Practice (GLP)
Principles of GLP
QMS- Enterprise Technology Quality (ETQ)
Principles of ETQ
QMS- MasterControl
MasterControl Principles
QMS- TrackWise
QMS- TrackWise
Industry Specific Standards- ISO 13485 & ISO 17025
Principles of ISO 13485 and ISO 17025
Good Clinical Practice (GCP)
Principles of GCP
Good Distribution Practices (GDP)
Principles of GDP
Additional QMS Software
SAP QM (Quality Management)
An integrated module within SAP’s ERP (Enterprise Resource Planning) system that enables companies to manage quality processes such as inspection planning, batch management, and quality notifications.
ComplianceQuest
A cloud-based QMS platform tailored for life sciences companies, providing functionalities for document control, training management, audit management, and supplier quality management.
Pilgrim SmartSolve
A QMS software suite offering modules for document management, CAPA, audit management, and risk management, designed to help pharmaceutical companies comply with regulatory requirements and improve product quality.
DB 2024.4.18